Global Trend of Survival and Damage of Systemic Lupus Erythematosus: Meta-Analysis and Meta-Regression of Observational Studies from the 1950s to 2000s

Seminars in Arthritis and Rheumatism

Volumn 41, Issue 6, 2012, Pages 830-839

  Mak, Anselm ^a   Cheung, Mike W L ^a   Chiew, Hui Jin ^a   Liu, Yang ^a   Ho, Roger Chun man ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Damage; Lupus; Meta analysis; Neuropsychiatric; Renal; SLE; Survival

Indexed keywords

ARTICLE; CARDIOVASCULAR INJURY; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; EARLY DIAGNOSIS; EFFECT SIZE; HUMAN; INFECTION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; META ANALYSIS (TOPIC); META REGRESSION; MUSCULOSKELETAL INJURY; NERVOUS SYSTEM INJURY; OBSERVATIONAL STUDY; ORGAN INJURY; OVERALL SURVIVAL; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLICATION; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS;

CROSS-SECTIONAL STUDIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 84862795876     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2011.11.002     Document Type: Article

References (33)

1. Gualtierotti R., Biggioggero M., Penatti A.E., Meroni P.L. Updating on the pathogenesis of systemic lupus erythematosus. Autoimmun Rev 2010, 10:3-7.
2. Doria A., Briani C. Lupus: improving long-term prognosis. Lupus 2008, 17(3):166-170.
3. Petri M. Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2002, 16:847-858.
4. Chambers S.A., Allen E., Rahman A., Isenberg D. Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years. Rheumatology (Oxford) 2009, 48:673-675.
5. Tam L.S., Wong A., Mok V.C., Zhu Y.E., Kwok L.W., Li T.K., et al. The relationship between neuropsychiatric, clinical, and laboratory variables and quality of life of Chinese patients with systemic lupus erythematosus. J Rheumatol 2008, 35:1038-1045.
6. Bultink I.E., Turkstra F., Dijkmans B.A., Voskuyl A.E. High prevalence of unemployment in patients with systemic lupus erythematosus: association with organ damage and health-related quality of life. J Rheumatol 2008, 35:1053-1057.
7. Mak A. The economic burden of systemic lupus erythematosus in Asia: the current state. Lupus 2010, 19:1442-1446.
8. Lau C.S., Mak A. The socioeconomic burden of SLE. Nat Rev Rheumatol 2009, 5:400-404.
9. Gladman D., Ginzler E., Goldsmith C., Fortin P., Liang M., Urowitz M., et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996, 39:363-369.
10. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
11. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement [electronic article]. PLoS Med 2009, 6:e1000097. PRISMA Group.
12. Viechtbauer W. Conducting meta-analysis in R with the metaphor package. J Statist Softw 2010, 36(3):1-48.
13. Fless J.L., Levin B., Paik M.C. Statistical methods for rates of proportions 2003, John Wiley, Hoboken (NJ).
14. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
15. Fletcher J. What is heterogeneity and is it important?. BMJ 2007, 334:94-96.
16. Cohen A.S., Reynolds W.E., Franklin E.C. Preliminary criteria for the classification of systemic lupus erythematosus. Bull Rheum Dis 1971, 21:643-648.
17. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277.
18. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40:1725.
19. Hedges L.V., Tipton E., Johnson M.C. Robust variance estimation in meta-regression with dependent effect size estimates. Res Synth Meth 2010, 1:39-65.
20. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
21. Duval S., Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000, 56:455-463.
22. Mak A., Mok C.C., Chu W.P., To C.H., Wong S.N., Au T.C. Renal damage in systemic lupus erythematosus: a comparative analysis of different age groups. Lupus 2007, 16:28-34.
23. Mok C.C. Prognostic factors in lupus nephritis. Lupus 2005, 14:39-44.
24. Ginzler E.M., Diamond H.S., Weiner M., Schlesinger M., Fries J.F., Wasner C., et al. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum 1982, 25:601-611.
25. Blanco F.J., Gómez-Reino J.J., de la Mata J., Corrales A., Rodríguez-Valverde V., Rosas J.C., et al. Survival analysis of 306 European Spanish patients with systemic lupus erythematosus. Lupus 1998, 7:159-163.
26. Mikdashi J., Handwerger B. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort. Rheumatology (Oxford) 2004, 43:1555-1560.
27. Mok C.C., To C.H., Mak A. Neuropsychiatric damage in Southern Chinese patients with systemic lupus erythematosus. Medicine (Baltimore) 2006, 85:221-228.
28. Stanley M. Prophylactic human papillomavirus vaccines: will they do their job?. J Intern Med 2010, 267:251-259.
29. Doria-Rose V.P., Marcus P.M., Szabo E., Tockman M.S., Melamed M.R., Prorok P.C. Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study. Cancer 2009, 115:5007-5017.
30. Duffy S.W., Mackay J., Thomas S., Anderson E., Evans D.G., Fielder H., et al. Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study. Lancet Oncol 2010, 11:1127-1134.
31. Pons-Estel B.A., Catoggio L.J., Cardiel M.H., Soriano E.R., Gentiletti S., Villa A.R., et al. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among "Hispanics". Medicine (Baltimore) 2004, 83:1-17.
32. Wadee S., Tikly M., Hopley M. Causes and predictors of death in South Africans with systemic lupus erythematosus. Rheumatology (Oxford) 2007, 46:1487-1491.
33. Kuan W.P., Li E.K., Tam L.S. Lupus organ damage: what is damaged in Asian patients?. Lupus 2010, 19:1436-1441.